Largest pharmaceutical companies by cash on hand
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Veradermics has the lowest figure of the 61 pharmaceutical companies ranked by cash on hand, at SAR 81.7M, followed by Oruka Therapeutics (SAR 176.1M) and Dianthus Therapeutics (SAR 191.7M). Figures as of 19 Nov 2026, 01:47 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- VeradermicsSAR 81.7M
- Median
- SAR 2.2B
- Combined market value
- SAR 18.98T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Cash on hand ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | VeradermicsMANE · Health Care | SAR 81.7M | SAR 19.8B | SAR 468.41 | 0.62% down | 233% up | ||
| 2 | Oruka TherapeuticsORKA · Health Care | SAR 176.1M | SAR 24.4B | SAR 359.17 | 0.60% down | 241% up | ||
| 3 | Dianthus TherapeuticsDNTH · Health Care | SAR 191.7M | SAR 17.7B | SAR 315.05 | 3.45% down | 113% up | ||
| 4 | Rhythm PharmaceuticalsRYTM · Health Care | SAR 203.7M | SAR 31B | SAR 446.58 | 2.08% up | 13% up | ||
| 5 | Edgewise TherapeuticsEWTX · Health Care | SAR 229.4M | SAR 17B | SAR 155.20 | 1.59% down | 88% up | ||
| 6 | ErascaERAS · Health Care | SAR 276.9M | SAR 18.1B | SAR 51.62 | 0.94% down | 403% up | ||
| 7 | TG TherapeuticsTGTX · Health Care | SAR 296.9M | SAR 37.5B | SAR 248.05 | 5.44% up | 107% up | ||
| 8 | Spyre TherapeuticsSYRE · Health Care | SAR 321.6M | SAR 36.1B | SAR 380.63 | 8.15% up | 286% up | ||
| 9 | Travere TherapeuticsTVTX · Health Care | SAR 349M | SAR 18.1B | SAR 188.48 | 1.68% down | 44% up | ||
| 10 | Corcept TherapeuticsCORT · Health Care | SAR 452M | SAR 27.8B | SAR 254.31 | 3.25% down | 8% down | ||
| 11 | CytokineticsCYTK · Health Care | SAR 459.6M | SAR 26.8B | SAR 192.53 | 0.64% down | 20% down | ||
| 12 | Protagonist TherapeuticsPTGX · Health Care | SAR 481.7M | SAR 31.1B | SAR 477.04 | 2.00% up | 46% up | ||
| 13 | Dr. Reddy's LaboratoriesRDY · Health Care | SAR 613.5M | SAR 46.8B | SAR 56.20 | 1.28% up | 5% up | ||
| 14 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SAR 621.2M | SAR 28B | SAR 356.58 | 0.06% down | 126% up | ||
| 15 | Ligand PharmaceuticalsLGND · Health Care | SAR 656.2M | SAR 22.4B | SAR 1,120.61 | 1.67% up | 43% up | ||
| 16 | Madrigal PharmaceuticalsMDGL · Health Care | SAR 745.4M | SAR 34.7B | SAR 1,493.40 | 5.67% down | 24% down | ||
| 17 | Summit TherapeuticsSMMT · Health Care | SAR 845.1M | SAR 31.5B | SAR 39.39 | 1.59% down | 36% down | ||
| 18 | Arrowhead PharmaceuticalsARWR · Health Care | SAR 849.9M | SAR 22.9B | SAR 161.73 | 0.28% up | 10% up | ||
| 19 | Definium TherapeuticsDFTX · Health Care | SAR 967.3M | SAR 15B | SAR 109.24 | 0.88% down | 169% up | ||
| 20 | Amneal PharmaceuticalsAMRX · Health Care | SAR 1.1B | SAR 28.6B | SAR 82.08 | 3.60% up | 83% up | ||
| 21 | Mirum PharmaceuticalsMIRM · Health Care | SAR 1.1B | SAR 22.7B | SAR 346.98 | 0.59% up | 31% up | ||
| 22 | Cogent BiosciencesCOGT · Health Care | SAR 1.2B | SAR 18.2B | SAR 104.33 | 0.14% down | 20% down | ||
| 23 | Axsome TherapeuticsAXSM · Health Care | SAR 1.2B | SAR 26.4B | SAR 502.70 | 1.43% down | 7% down | ||
| 24 | Belite BioBLTE · Health Care | SAR 1.3B | SAR 23.8B | SAR 586.10 | 0.94% down | 31% up | ||
| 25 | Praxis Precision MedicinesPRAX · Health Care | SAR 1.3B | SAR 32B | SAR 1,144.92 | 0.04% up | 61% up | ||
| 26 | Ionis PharmaceuticalsIONS · Health Care | SAR 1.4B | SAR 17.1B | SAR 102.75 | 1.59% up | 64% down | ||
| 27 | AlkermesALKS · Health Care | SAR 1.5B | SAR 29.5B | SAR 175.76 | 3.08% up | 58% up | ||
| 28 | InsmedINSM · Health Care | SAR 1.9B | SAR 98.6B | SAR 449.43 | 1.69% down | 40% down | ||
| 29 | Elanco Animal HealthELAN · Health Care | SAR 2B | SAR 50.1B | SAR 100.17 | 3.29% up | 20% up | ||
| 30 | BridgeBio PharmaBBIO · Health Care | SAR 2.1B | SAR 57B | SAR 292.65 | 1.58% up | 17% up | ||
| 31 | ABIVAXABVX · Health Care | SAR 2.2B | SAR 27.5B | SAR 314.49 | 2.11% up | 27% down | ||
| 32 | Royalty PharmaRPRX · Health Care | SAR 2.3B | SAR 148.1B | SAR 257.62 | 0.01% down | 78% up | ||
| 33 | Ascendis PharmaASND · Health Care | SAR 2.6B | SAR 66.5B | SAR 1,014.14 | 0.32% down | 28% up | ||
| 34 | Legend BiotechLEGN · Health Care | SAR 3.4B | SAR 11.8B | SAR 60.96 | 0.87% up | 42% down | ||
| 35 | GrifolsGRFS · Health Care | SAR 3.4B | SAR 21.6B | SAR 31.78 | 1.85% down | 1% up | ||
| 36 | PTC TherapeuticsPTCT · Health Care | SAR 3.7B | SAR 18.9B | SAR 225.95 | 0.22% down | 20% down | ||
| 37 | PfizerPFE · Health Care | SAR 4.3B | SAR 600B | SAR 105.27 | 1.44% down | 14% up | ||
| 38 | BioMarin PharmaceuticalBMRN · Health Care | SAR 4.9B | SAR 44.6B | SAR 230.45 | 4.99% up | 11% up | ||
| 39 | ViatrisVTRS · Health Care | SAR 5B | SAR 87.2B | SAR 76.08 | 0.83% down | 96% up | ||
| 40 | Jazz PharmaceuticalsJAZZ · Health Care | SAR 5.2B | SAR 59.7B | SAR 929.51 | 2.93% up | 37% up | ||
| 41 | Roivant SciencesROIV · Health Care | SAR 5.3B | SAR 105.3B | SAR 145.30 | 0.05% up | 90% up | ||
| 42 | United TherapeuticsUTHR · Health Care | SAR 5.8B | SAR 92.2B | SAR 2,165.89 | 1.16% down | 23% up | ||
| 43 | Alnylam PharmaceuticalsALNY · Health Care | SAR 6.2B | SAR 75.1B | SAR 560.47 | 4.54% down | 66% down | ||
| 44 | GenmabGMAB · Health Care | SAR 6.4B | SAR 117.9B | SAR 191.21 | 1.91% down | 70% up | ||
| 45 | ZoetisZTS · Health Care | SAR 8.7B | SAR 130.4B | SAR 321.02 | 2.50% up | 29% down | ||
| 46 | Regeneron PharmaceuticalsREGN · Health Care | SAR 11.7B | SAR 366.9B | SAR 3,547.16 | 1.28% down | 36% up | ||
| 47 | Teva Pharmaceutical IndustriesTEVA · Health Care | SAR 13.3B | SAR 184.9B | SAR 158.43 | 0.92% down | 74% up | ||
| 48 | Takeda PharmaceuticalTAK · Health Care | SAR 14B | SAR 254.9B | SAR 79.79 | 1.71% down | 54% up | ||
| 49 | Novo NordiskNVO · Health Care | SAR 14.7B | SAR 651.9B | SAR 147.92 | 3.12% down | 17% down | ||
| 50 | GSKGSK · Health Care | SAR 16.9B | SAR 365.3B | SAR 182.25 | 1.34% down | 6% up | ||
| 51 | BeOne MedicinesONC · Health Care | SAR 17.1B | SAR 173B | SAR 1,514.11 | 2.34% down | 17% up | ||
| 52 | Vertex PharmaceuticalsVRTX · Health Care | SAR 19.1B | SAR 510.2B | SAR 2,012.49 | 0.42% up | 27% up | ||
| 53 | AbbVieABBV · Health Care | SAR 19.6B | SAR 1.9T | SAR 1,072.97 | 2.33% down | 26% up | ||
| 54 | AstraZenecaAZN · Health Care | SAR 21.4B | SAR 1.04T | SAR 670.62 | 1.93% down | 2% up | ||
| 55 | Eli LillyLLY · Health Care | SAR 27.3B | SAR 4.62T | SAR 5,187.39 | 2.32% down | 35% up | ||
| 56 | SanofiSNY · Health Care | SAR 31.9B | SAR 424.5B | SAR 176.77 | 0.86% down | 4% down | ||
| 57 | Abbott LaboratoriesABT · Health Care | SAR 32B | SAR 678.8B | SAR 391.96 | 0.22% down | 17% down | ||
| 58 | Bristol-Myers SquibbBMY · Health Care | SAR 38.3B | SAR 456.7B | SAR 223.44 | 2.92% down | 34% up | ||
| 59 | NovartisNVS · Health Care | SAR 42.9B | SAR 1.1T | SAR 582.27 | 2.46% down | 25% up | ||
| 60 | Merck & CoMRK · Health Care | SAR 54.6B | SAR 1.27T | SAR 516.88 | 3.90% down | 51% up | ||
| 61 | Johnson & JohnsonJNJ · Health Care | SAR 73.9B | SAR 2.46T | SAR 1,023.03 | 2.15% down | 38% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7515 SAR).
Questions and answers
Which pharmaceutical companies have the lowest cash on hand?
Veradermics (SAR 81.7M), Oruka Therapeutics (SAR 176.1M) and Dianthus Therapeutics (SAR 191.7M) have the lowest cash on hand of the 61 pharmaceutical companies ranked here as of 19 Nov 2026, 01:47 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by cash on hand.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by cash on hand have a combined market value of SAR 18.98T as of 19 Nov 2026, 01:47 UTC.
What does ranking by cash on hand measure?
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by cash on hand”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=cash-on-hand
Underlying data: Yahoo Finance; SEC EDGAR.